Website

IMARA Inc. (IMRA) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for IMRA in the last 30 days. The most recent was published Jun 30, 2026.

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, an oral, once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.

News · 26 weeks30%
2026-05-17: 12026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 12026-06-28: 12026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 02026-11-08: 0
2026-05-172026-11-08
Mix090d

No activity.

Activity · 52 weeks99 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

IMRA FAQ

8 questions
  • What does IMARA Inc. do?
    IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, an oral, once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
  • What is the latest news on IMRA?
    Quantisnow has not tracked any new filings, ratings or press releases for IMRA in the last 30 days. The most recent wire item was published on June 30, 2026.
  • Where does IMRA stock trade?
    IMARA Inc. (IMRA) is listed on NASDAQ.
  • What sector and industry is IMRA in?
    IMARA Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • When did IMARA Inc. go public?
    IMARA Inc. (IMRA) completed its IPO in 2020.
  • What are analysts saying about IMRA?
    Across the last 3 analyst actions on IMARA Inc., there were 0 upgrades and 1 downgrade. The most recent action was from Morgan Stanley: Equal-Weight with a $4.00 price target on 2022-01-06. Recent price targets range from $4.00 to $12.00.
  • What companies are similar to IMRA?
    Notable peers in the same industry include AMGN (Amgen Inc.), EXEL (Exelixis Inc.), ARGX (argenx SE), MRNA (Moderna Inc.), RVMD (Revolution Medicines Inc.). Compare IMRA side-by-side with any of them on Quantisnow.
  • How can I track IMRA on Quantisnow?
    Quantisnow aggregates IMARA Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IMRA to receive live email and push alerts on every new disclosure.